Economic evaluation of ticagrelor for secondary prevention following acute coronary syndromes

Introduction and Objectives: To estimate the cost-effectiveness and cost-utility of ticagrelor in the treatment of patients with acute coronary syndromes (unstable angina or myocardial infarction with or without ST-segment elevation), including patients treated medically and those undergoing percuta...

Full description

Bibliographic Details
Main Authors: Miguel Gouveia, Margarida Borges, Rosário Trindade, Klas Rikner
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:Revista Portuguesa de Cardiologia (English Edition)
Online Access:http://www.sciencedirect.com/science/article/pii/S2174204915000021